Conn. Gen. Stat. § 19a-269b
Screening for kidney disease. Clinical laboratories
Connecticut · General Statutes of Connecticut Chapter 368h — Kidney Disease · Status: effective
Cite this
- Citation
- Conn. Gen. Stat. § 19a-269b, Screening for kidney disease. Clinical laboratories, Connecticut, version 1 as recorded 2026-10-03, yourstate.us, https://yourstate.us/provision/2185343
- Permanent ID
ys:prov:2185343@1- SHA-256
9334845d7e59eefaf2cd92ae349144b13c9f40a1e42a7bae7dd52fb4cb1d0dde
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) As used in this section, “clinical laboratory” has the same meaning as provided in section 19a-490.
(b) Beginning September 1, 2006:
(1) Any person, firm or corporation operating a clinical laboratory licensed in this state shall ensure that when the clinical laboratory tests a specimen to determine a patient's serum creatinine level, as ordered or prescribed by a physician or provider in a hospital, the clinical laboratory shall (A) calculate the patient's estimated glomerular filtration rate using the patient's age and gender, which information shall be provided to the clinical laboratory by the physician or the provider in a hospital, and (B) include the patient's estimated glomerular filtration rate with its report to the physician or the provider in a hospital.
(2) A person, firm or corporation operating a clinical laboratory licensed in this state shall be deemed in compliance with subdivision (1) of this subsection if the clinical laboratory makes available to the ordering physician or provider in a hospital test order codes for serum creatinine that include eGFR.